Workflow
新股消息 | 丹诺医药、欣旺达(300207.SZ)拟港股IPO已获中国证监会接收材料
SUNWODASUNWODA(SZ:300207) 智通财经网·2025-08-11 01:57

Group 1: Danuo Pharmaceutical - Danuo Pharmaceutical is a biotechnology company established in 2013, focusing on the discovery, development, and commercialization of innovative drug products to address unmet clinical needs in bacterial infections and related diseases [1] - The company has developed a differentiated pipeline consisting of seven innovative assets, including three core products: TNP-2198, the world's first and only new molecular entity candidate drug for treating Helicobacter pylori infection; TNP-2092 injection, a potential first-in-class candidate drug for treating implant-related bacterial infections; and TNP-2092 oral formulation, the world's first multi-target candidate drug for treating gut microbiota-related metabolic diseases [1] Group 2: Xinwanda - Xinwanda is a global lithium battery technology company dedicated to providing green and efficient integrated solutions for new energy [2] - The company is involved in the research, design, manufacturing, and sales of lithium batteries, covering a wide product matrix that includes consumer batteries, power batteries, and energy storage systems, offering comprehensive solutions from cell to module to system, as well as battery testing and recycling [2] - Xinwanda has established long-term stable partnerships with leading global technology companies, including major smartphone manufacturers such as Xiaomi, Lenovo, OPPO, vivo, Honor, and Transsion, with all top ten global smartphone manufacturers in 2024 being its customers [2]